Cello World Limited — Results, 23-05-2025: Integrated Filing- Financial
Cello World Limited has announced a board meeting on August 8, 2025, to consider the financial results for the quarter and half-year.
Revenue Performance: Consolidated revenue for the year ended March 31, 2025, rose 6.9% YoY to ₹21,363.88 Cr, driven mainly by its consumer products segment. This steady growth reflects sustained demand in its core business.
Profitability and EPS: Net profit after tax increased modestly by 2.3% to ₹3,645.67 Cr, with EPS at ₹15.50. Profit before tax improved to ₹4,912.88 Cr, and margins remained stable despite rising input and employee costs, indicating efficient cost management.
Operational Costs: Expenses increased primarily due to higher raw material consumption and employee costs rising from ₹189.46 Cr to ₹211.18 Cr. Depreciation and amortization rose 9.3% to ₹61.99 Cr, linked to new capex. Finance costs slightly declined, reflecting some cost efficiency.
Key Metrics: EBITDA stands healthy at around ₹4,919 Cr, supporting operational scalability. Inventory buildup of about ₹62.42 Cr suggests preparation for anticipated demand. Other comprehensive income recorded a minor net loss due to investment valuation changes.
Balance Sheet / Cash Flow Health: Total assets reached ₹26,418 Cr with equity at ₹24,085 Cr. Borrowings plunged drastically to ₹0.50 Cr from ₹335 Cr, signaling strong deleveraging. Cash balances increased to ₹51.69 Cr. Large investing cash outflows (₹553.43 Cr) reflect capex and investments, balanced by a ₹713.12 Cr equity infusion, bolstering liquidity and growth capacity.
Management Commentary / Strategic Outlook: The newly commissioned glassware plant and plans to expand product lines indicate growth focus. A new ESOP scheme aims to retain talent, while a recommended 30% final dividend signals confidence in cash flow sustainability. Ongoing restructuring among subsidiaries is expected to enhance business efficiency.
Final Takeaway: Cello World presents steady revenue growth, stable margins, and a robust balance sheet after strong equity infusion and debt reduction. Expansion efforts and disciplined cash management provide a positive medium-term outlook. Retail investors can take comfort from dividend visibility and deleveraging progress as signs of financial health.
